Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

45results about How to "Promotes collagen production" patented technology

Methods and systems for laser treatment using non-uniform output beam

ActiveUS7856985B2Minimizing risk of burning and other damagePromotes collagen productionDiagnosticsSurgical instrument detailsCollagen shrinkageNd:YAG laser
Methods and apparatus for treatment, such as skin rejuvenation treatment, using non-uniform laser radiation. A high-intensity portion of the laser radiation causes collagen destruction and shrinkage within select portions of the treatment area, while a lower-intensity portion of the radiation causes fibroblast stimulation leading to collagen production across other portions of the treatment area. An output beam from a laser source, such as an Nd:YAG laser, is coupled into an optical system that modifies the beam to provide a large-diameter beam having a non-uniform energy profile, comprised of a plurality of high-intensity zones surrounded by lower-intensity zones within the treatment beam. The higher-intensity zones heat select portions of the target tissue to temperatures sufficient for a first treatment (e.g. collagen shrinkage), while the lower-intensity zones provide sufficient energy for a second treatment (e.g. stimulated collagen production). A large area of tissue, preferably 7-10 mm in diameter, can be treated simultaneously, while minimizing the risk of burning or other damage to the skin.In one embodiment, the invention uses a fiber bundle to provide a non-uniform energy output beam. In another embodiment, the invention uses a diffractive lens array to produce the non-uniform output beam. A cooling system can also be integrated with the laser treatment system.
Owner:CYNOSURE

Composition for acceleration of type i collagen production

It is an object of the present invention to provide a composition for promoting the production of type I collagen by human skin fibroblasts, and the present invention relates to a composition for promoting type I collagen production containing silybin and a peptide that promotes collagen production (peptide having an amino acid sequence of Gly-Pro-Hyp, Gly-His-Lys, Lys-Thr-Thr-Lys-Ser or Gly-Glu-Pro-Arg).
Owner:FUAN KERU

Direct application system and method for the delivery of bioactive compositions and formulations

The embodiments relate to improved skin quality, health and appearance using a new delivery method and certain bioactive compositions and formulations. The system incorporates microneedle delivery technology with unique compositions and formulations. Such development allows for the pursuit of personalized medicine, or treatment delivery that can expand to remote controlled environment, immediate compounding and ultimate personalization with a state of the art longitudinal data predictive analytics. Certain formulations described herein are unique, combinatory and synergistic. Secured by high-tech proprietary system, there are unlimited potentials using AQT technology including but not limited to 3-D printing of a biodegradable micro chips that can be delivered via injection, AQT or any other possible route.
Owner:AQUAVIT PHARMA

Skin wrinkle treatment

A method for treating skin may first involve contacting an applicator of a skin heating device with an epidermal layer of the skin. The applicator may be activated to generate high-frequency alternating magnetic fields. The applicator may be used to heat a dermal layer of the skin, with the high-frequency alternating magnetic fields, to a temperature of less than 40 degrees Celsius, to stimulate a release of heat shock protein in the dermal layer to promote collagen generation. The method may also involve limiting heating of the dermal layer of the skin to less than 40 degrees Celsius.
Owner:LIFE CARE MEDICAL DEVICES

Skin remodeling and regenerative compositions containing elastin peptide ligands having the amino acid sequence (XGXXPG)n

The present invention relates to skin care compositions providing a method of enhancing the remodeling of age damaged and sun damaged skin in mammals utilizing an elastin peptide (EP) ligand of the general formula (GXXPG)n and in particular the sequences of (VGVAPG)n and / or (GVAPGV)n, and / or (VAPGVG)n and / or (APGVGV)n and / or (PGVGVA)n and / or (GVGVAP)n and a galactosugar which modulates the effect of the elastin peptide ligand(EP) on its lectin the Elastin-Binding Receptor (EBR). wherin A is a peptide-forming residue of L-alanine; G is a peptide-forming residue of glycine P is a peptide-forming residue of L-proline V is a peptide-forming residue of L-valine X is a peptide-forming residue of a single unspecified amino acid Peptide representations in this application conform to the standard practice of writing the NH2-terminal amino acid residue at the left of the formula and the CO2 H-terminal amino acid residue at the right.
Owner:ALBIN ERIC L

Non-uniform beam optical treatment methods and systems

InactiveUS20130096546A1Large area of patientPromote absorptionSurgical instrument detailsLight therapyHigh energyNon uniform beam
An apparatus is disclosed including: an incoherent light source that generates a treatment beam having a non-uniform energy profile, the non-uniform energy profile being included of regions of relatively high energy per unit area within a substantially uniform background region of relatively low energy per unit area.
Owner:CYNOSURE

Compound for neck skin firming

A topical compound for reducing sagging or wrinkles in the neck area of human skin. The compound includes safe and effective amounts of a mild topical astringent (such as Camphor) for skin tightening, a topical antispasmodic (such as benzyl cinnamate) for skin smoothing, and a topical skin irritant to increase localized skin circulation. The compound can also optionally include palmitoyl pentapeptide-3 to stimulate production of collagen and elastin in skin, a mushroom ferment extract to increase the cell turnover rate skin, and to increase hydration, skin firmness and elimination of fine facial lines, a cocao ferment extract to inhibit lipid peroxidation, inhibit excess ornithine decarboxylase activity, and stimulate cutaneous blood flow to reduce lines and wrinkles, and a Lactobacillus lysate extract to stimulate collagen production. These ingredients are mixed in a dermatologically acceptable carrier for topical application.
Owner:BROWN VERA +1

Methods for Identifying Areas of a Subject's Skin that Appear to Lack Volume

The present embodiments relate to methods and systems for identifying areas of a subject's skin that lack sufficient volume. In some embodiments, this can be used to direct the administration of filler compositions or the application of techniques that increase the volume or firmness of the area. In some embodiments, the methods and systems provide for improved aesthetic benefit as well as suitability for instruction and training. In some embodiments, the methods are especially useful in the administration of dermal fillers to a subject.
Owner:IPSYRNG CAPITAL DEV

Device for the treatment of the vaginal canal and relevant equipment

InactiveUS20130006334A1Stimulate collagen productionAtrophic vaginitis is prevented or treatedLight therapyObstetrical instrumentsVaginal canalGynecology
The device for the treatment of the vaginal canal by a laser beam, comprises a vaginal canal wall retractor, associated to a system for directing the laser beam towards said wall.
Owner:EL EN SPA

Direct application system and method for the delivery of bioactive compositions and formulations

InactiveUS20200121769A1Stimulate collagen productionFaster onsetCosmetic preparationsOrganic active ingredientsPersonalizationBiomedical engineering
The embodiments relate to improved skin quality, health and appearance using a new delivery method and certain bioactive compositions and formulations. The system incorporates microneedle delivery technology with unique compositions and formulations. Such development allows for the pursuit of personalized medicine, or treatment delivery that can expand to remote controlled environment, immediate compounding and ultimate personalization with a state of the art longitudinal data predictive analytics. Certain formulations described herein are unique, combinatory and synergistic. Secured by high-tech proprietary system, there are unlimited potentials using AQT technology including but not limited to 3-D printing of a biodegradable micro chips that can be delivered via injection, AQT or any other possible route.
Owner:AQUAVIT PHARMA

Oxygen ion suspension nanometer gold foil stock solution and preparation method of oxygen ion suspension nanometer gold foil stock solution

The invention discloses an oxygen ion suspension nanometer gold foil stock solution and a preparation method of the oxygen ion suspension nanometer gold foil stock solution, and mainly relates to the field of a skin care product. The oxygen ion suspension nanometer gold foil stock solution comprises the following ingredients in percentage by weight: 30 percent to 40 percent of deionized water, 10 percent to 18 percent of hyaluronic acid, 10 percent to 15 percent of water-solubility collagen, 10 percent to 20 percent of levo Vc, 5 percent to 8 percent of allantoin, 1 percent to 3 percent of sorbitol, 0.1 percent to 1 percent of carbomer, 1 percent to 3 percent of PPG (polypropylene glycol)-4 cetanol polyether-20, 15 percent to 25 percent of gold foil and 3 percent to 5 percent of negative oxygen ions. The oxygen ion suspension nanometer gold foil stock solution has the advantages that good whitening, moisture preserving and anti-wrinkle antioxidation efficacies are achieved; the gold foil can be uniformly suspended; the conduction and revitalizing functions of the gold foil are fully exerted; the water curing performance is obviously improved.
Owner:晋中开发区小眼睛网络科技有限公司

Gm-csf cosmeceutical compositions and methods of use thereof

It has been discovered that granulocyte macrophage colony stimulating factor (“GM-CSF”) promotes migration of activated (but not differentiating) keratinocytes to wound sites. It was also discovered that GM-CSF increases the quantity and improves the quality of collagen. This growth factor specifically increases migration of keratinocytes of the “wound” phenotype but does not have significant effects upon differentiated keratinocytes. Examples demonstrate reversal of skin impairment in multiple animal models of diabetic skin imparment when provided in an effective amount over an effective time period. The examples also demonstrate the efficacy of the formulations in cosmetic applications. A preferred formulation is a sustained release formulation that delivers sufficient growth factor to the skin and the underlying tissue thereof to increase the rate of keratinocyte migration, as well as collagen deposition and fibroblast proliferation, in the skin to promote rejuvenation of skin injuries resistant to repair due to underlying disease, such as diabetes, or aging.
Owner:NEW YORK UNIV

Ferulic ester derivative, 3,9-diferulylcoumestrol and cosmetic product containing same

The present invention relates to a skin cosmetic product containing 3,9-diferulylcoumestrol, especially to a skin cosmetic product containing a compound in which ferulylic acid is bonded to a coumestrol. The skin cosmetic product has several excellent effects for improving cosmetic disorders, such as anti-aging effect, whitening effect and hair-seeding effect.
Owner:HANBUL COSMETICS

Cosmetic Compositions Comprising Marine Plants

The present invention relates to a cosmetic active ingredient for improving the appearance of the skin beneath the eyes. More particularly, the present invention relates to a cosmetic active ingredient comprising an extract of the marine algae, Fucus vesiculosus. The present invention also relates to topical cosmetic compositions comprising as an active component an extract of the marine algae, Fucus vesiculosus, alone or in combination with additional cosmetic active ingredients, to reduce the appearance of dark circles in skin beneath the eye.
Owner:BASF CORP

Composition containing chamaecyparis obtusa polysaccharides to be externally applied to the skin

The present invention relates to a composition for skin external application containing a Chamaecyparis obtusa polysaccharide as an active ingredient, and more particularly to a composition for skin external application containing a Chamaecyparis obtusa polysaccharide, which improves skin elasticity and reduces wrinkles by promoting collagen production, shows an excellent skin-whitening effect by inhibiting melanogenesis, improves skin moisturization by promoting keratinocyte differentiation, and has excellent anti-inflammatory and skin regeneration effects.
Owner:AMOREPACIFIC CORP

Topical cosmetic compositions

ActiveUS20170172911A1Improve skin textureImprove clarityCosmetic preparationsAntipyreticVEGF productionTumor necrosis factor alpha
Disclosed are compositions and methods for their use for reducing tumor necrosis factor alpha (TNF-α) and / or vascular endothelial growth factor (VEGF) production in skin cells by topically applying to skin in need thereof, a composition comprising an effective amount of Opuntia ficus-indica tuna, Opuntia ficus-indica nopales, or both, or extracts thereof, to reduce TNF-α or VEGF production in skin cells.
Owner:MARY KAY INC

Pharmaceutical compositions for treating ebola virus disease

The present invention provides compounds and pharmaceutical compositions adapted to reduce a load of an RNA virus by at least 50%, the virus causing a pathogenic disease in a mammalian subject, the compound adapted to inhibit the formation of S-adenosyl methionine (SAM) in the virus, the compound being a DOTIL inhibitor, wherein the compound has a molecular weight of less than 1000, and a therapeutic index (TI=ED50 / LD50) greater than 30 in the mammalian subject.
Owner:VECHT LIFSHITZ SUSAN EVE

Composition for promoting collagen production

Disclosed is a novel composition which has an effect on promoting production of collagen. The composition has high photostability and is free from side effects such as those of retinoids. Specifically disclosed is a composition for promoting collagen production which contains one or more compounds selected from the group consisting of D-aspartic acid, D-alanine, derivatives and / or salts thereof. The composition may be used for the purpose of suppressing and / or improving skin a condition. The skin condition may include but is not limited to photoaging and / or wrinkles. The composition may be used for an external preparation for the skin or food. The composition may be a composition for promoting type I collagen production.
Owner:SHISEIDO CO LTD

Fermentation product of punica granatum and uses thereof

The present disclosure provides a fermentation product of Punica granatum and methods for regulating expression of MMP gene, TIMP gene and COL4A4 gene, promoting collagen production, and anti-aging by using the fermentation product of Punica granatum.
Owner:TCI CO LTD

Pharmaceutical composition for preventing or treating aging-related diseases containing decursin derivative as active ingredient

The present invention relates to a novel decursin derivative and a composition for preventing or treating aging-related diseases containing the same as an active ingredient. The novel decursin derivative has exhibited an excellent effect of inhibiting progerin expression and an excellent effect of inhibiting binding between progerin and lamin A, and it has been confirmed that the novel decursin derivative prolongs the survival period of animal models in which progeria is induced. Therefore, a compound of the present invention can be effectively used for the prevention or treatment of aging-related diseases such as progeria, etc.
Owner:PRG S&TECH INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products